Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- And post-exposure rabies prophylaxis

Expert Review of Vaccines

Volumn 13, Issue 12, 2014, Pages 1593-1601

  Tantawichien, Terapong ^a,b   Sibunruang, Suda ^a   Tantawichien, Thanphet ^a   Angsanakul, Jaruboot ^a   Benjavongkulchai, Maneerat ^a   Limsuwan, Kornvika ^a   Udomchaisakul, Piyada ^a   Khomvilai, Sumana ^a   Sitprija, Visith ^a  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Intradermal injection; Post exposure prophylaxis; Pre exposure prophylaxis; Rabies vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; DRUG FEVER; DRUG SAFETY; ERYTHEMA; FEMALE; GEOMETRY; HUMAN; IMMUNOGENICITY; MALE; MYALGIA; NORMAL HUMAN; PAIN; POST EXPOSURE PROPHYLAXIS; PRE EXPOSURE PROPHYLAXIS; PROPHYLAXIS; PROSPECTIVE STUDY; PRURITUS; RABIES; RABIES VIRUS; THAILAND; VACCINATION; VERO CELL LINE; ADOLESCENT; ANIMAL; BLOOD; CHLOROCEBUS AETHIOPS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PRE-EXPOSURE PROPHYLAXIS; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; POST-EXPOSURE PROPHYLAXIS; PRE-EXPOSURE PROPHYLAXIS; PROSPECTIVE STUDIES; RABIES; RABIES VACCINES; TREATMENT OUTCOME; VERO CELLS; YOUNG ADULT;

EID: 84909643422     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.971764     Document Type: Article

References (49)

1. World Health Organization. WHO Expert Consultation on Rabies. Second report. World Health Organ Tech Rep Ser 2013;982:1-139
2. World Health Organization. Rabies vaccine: WHO position paper. Weekly Epidemiol Rec 2010;85:309-20
3. Briggs DJ. The role of vaccination in rabies prevention. Curr Opinion Virol 2012;2: 309-14
4. Chutivongse S, Wilde H, Supish C, et al. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990;1:896-8
5. Briggs DJ, Banzhoff A, Nicolay U, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000; 78(5):693-8
6. Khawplod P, Wilde H, Sirikwin S, et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 2006; 24(16):3084-6
7. Quiambao BP, Dy-Tioco HZ, Dizon RM, et al. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines. Vaccine 2009;27:7162-6
8. Toovey S. Preventing rabies with the Verorab® vaccine: 1985-2005: Twenty years of clinical experience. J Travel Med Infect Dis 2007;5:327-48
9. Quiambao BP, Lang J, Vital S, et al. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomized clinical trial in the Philippines. Acta Trop 2000;75:39-52
10. Jones RL, Froeschle JE, Atmar RL, et al. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine 2001;19:4635-43
11. Arora A, Moeller L, Froeschle J. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine. J Travel Med 2004;11:195-200
12. Picot' N, LeMeneti V, Rotive Y, et al. Booster effect of a new chromatographically purified Vero cell rabies vaccine (CPRV): immunogenicity and safety of a single or double injection. Trans R Soc Trop Med Hyg 2001;95:242-4
13. Wang C, Zhang X, Song Q, Tang K. Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified Vero cell vaccine produced in China. Clin Vaccine Immunol 2010;17(4):688-90
14. Ling-yun W, Mei-ping S, Xue-chun Z, et al. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis. Vaccine 2011;29:2679-81
15. Sabchareon A, Chantavanich P, Pasuralertsakul S, et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 1998;17:1001-7
16. Phanuphak P, Khawplod P, Sirivichayakul S, et al. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac J Allergy Immunol 1987;5(1):33-7
17. Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973;48:535-41
18. Crowle AJ, Atkins A, May M. Induction of delayed hypersensitivity to protein antigens in mice without Freund's adjuvants. J Allergy Clin Immunol 1977;60:14-26
19. Warell MJ, Warell DA, Suntharsamai P, et al. An economical regimen of human diploid cell strain rabies vaccine for post-exposure prophylaxis. Lancet 1983; 2(8345):301-4
20. Warrell MJ, Suntharasamai P, Nicholson KG, et al. Multi-site intradermal and multisite subcutaneous rabies vaccination: improved economical regimens. Lancet 1984;1(8382):874-6
21. Warrell MJ, Warrell DA. Intradermal regimens for rabies postexposure prophylaxis: more confusion. Clin Infect Dis 2002;35:213-14
22. Madhusudana SN, Sanjay TV, Mahendra BJ, et al. Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1ml. Hum Vaccin 2006;2(5):200-4
23. Tantawichien T, Benjawongkulchai M, Limsuwan K, et al. Antibody response after a 4-site intradermal booster with cell-culture rabies vaccine. Clin Infect Dis 1999;28(5):1110-12
24. Tantawichien T, Tantawichien T, Supit C, et al. Three-year experience of a four-site intradermal booster vaccination with cell-culture rabies vaccine for post-exposure prophylaxis. Clin Infect Dis 2001;33:2085-7
25. The Asian Rabies Expert Bureau. Report of the sixth AREB meeting. Vaccine 2010;28:3265-8
26. Suwansrinon K, Wilde H, Benjavongkulchai M, et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Vaccine 2006;24:3878-80
27. Thraenhart O, Kreuzfelder E, Hillebrandt M, et al. Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 1994;71(3):287-92
28. Sood SK. Immunization for children traveling aboard. Pediatr Clin North Am 2000;47(2):435-48
29. Piyaphanee W, Shantavasinkul P, Phumratanaprapin W, et al. Rabies exposure risk among foreign backpackers in southeast Asia. Am J Trop Med Hyg 2010;82(6):1168-71
30. Goswami A, Plun-Favreau J, Nicoloyannis N, et al. The real cost of rabies post-exposure treatments. Vaccine 2005;23:2970-6
31. Verma R, Khanna P, Prinja S, Rajput M. Intra-dermal administration of rabies vaccines in developing countries. Human Vaccin 2011;7(7):792-4
32. Yu P, Huang Y, Zhang Y, et al. Production and evaluation of a chromatographically purified Vero cell rabies vaccine (PVRV) in China using microcarrier technology. Human Vaccin Immunother 2012;8(9):1230-5
33. Liu H, Huang G, Tang Q, et al. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Human Vaccin 2011;7:220-4
34. Frazzati-Gallina NM, Paoli RL, Mourão-Fuches RM, et al. Higher production of rabies virus in serum-free medium cell cultures on microcarriers. J Biotechnol 2001;92:67-72
35. Trabelsi K, Rourou S, Loukil H, et al. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. J Biotechnol 2006;121:261-71
36. Rourou S, Ark A, Velden T, Kallel H. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 2007;25:3879-89
37. Strady A, Lang J, Lienard M, et al. Antibody persistence following pre-exposure regimens of cell-culture rabies vaccine. J Infect Dis 1998;177:1290-5
38. Kositprara C, Limsuwan K, Wilde H, et al. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations. Clin Infect Dis 1997;25:614-15
39. Kamoltham T, Thinyounyong W, Phongchamnaphai P, et al. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe. J Pediatr 2007;151(2):173-7
40. Vien NG, Feroldi E, Lang J. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Trans Royal Soc Trop Med Hyg 2008;102:294-6
41. WHO Expert Committee on biological standardization. World Health Organ Tech Rep Ser 2007(941):1-340
42. Zoonoses control: WHO consultation on intradermal application of human rabies vaccines. Wkly Epidemiol Rec 1995;70:336-8
43. Ratanavongsiri J, Sriwanthana B, Ubol S, Phanuphak P. Cell-mediated immune response following intracutaneous immunisation with human diploid cell rabies vaccine. Asian Pac J Allergy Immunol 1985;3:187-90
44. Jaijaroensup W, Limusanno S, Khawplod P, et al. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination. J Travel Med 1999;6(4):234-7
45. Sudarshan MK, Gangaboraiah B, Ravish HS, Narayana DH. Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by ID route: results of a metaanalysis. Hum Vaccin 2010;6(7):562-5
46. Shantavasinkul P, Tantawichien T, Wilde H, et al. Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 2010;50(1):56-60
47. Jaiiaroensup W, Lang J, Thipkong P, et al. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. Vaccine 1998;16(16):1559-62
48. Immunogenicity and safety study of a new chromatographically purified Vero cell rabies vaccine with ID regimen and ERIG. Available from: http://clinicaltrials.gov/show/NCT01137045
49. Immune response in adults to PrEP and simulated booster PEP with a new CPRV. Available from: http://clinicaltrials.gov/show/NCT01603875